Literature DB >> 11737583

Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats.

B D Cowley1, S D Ricardo, S Nagao, J R Diamond.   

Abstract

BACKGROUND: Human autosomal-dominant polycystic kidney disease (ADPKD) is variable in the rate of deterioration of renal function, with end-stage renal disease (ESRD) occurring in only approximately 50% of affected individuals. Evidence suggests that interstitial inflammation may be important in the development of ESRD in ADPKD. Han:SPRD rats manifest ADPKD that resembles the human disease. Homozygous cystic (Cy/Cy) rats develop rapidly progressive PKD and die near age 3 weeks. Heterozygous (Cy/+) females develop slowly progressive PKD without evidence of renal dysfunction until the second year of life, whereas heterozygous (Cy/+) males develop more aggressive PKD with renal failure beginning by 8 to 12 weeks of age.
METHODS: To examine the relationship between proinflammatory chemoattractants and the development of interstitial inflammation and ultimately renal failure in ADPKD, we evaluated monocyte chemoattractant protein-1 (MCP-1) and osteopontin mRNAs and proteins in kidneys from Han:SRPD rats.
RESULTS: MCP-1 and osteopontin mRNAs, expressed at low levels in kidneys from normal (+/+) animals at all ages, were markedly elevated in kidneys from 3-week-old Cy/Cy animals. In kidneys from heterozygous (Cy/+) adults of either gender, MCP-1 and osteopontin mRNAs were more abundant than normal; MCP-1 mRNA was more abundant in Cy/+ males than in females. Thus, chemoattractant mRNA expression correlated with the development of renal failure in Cy/Cy and Cy/+ rats. Osteopontin mRNA, localized by in situ hybridization, was moderately expressed in the renal medulla of normal animals; however, this mRNA was expressed at very high levels in the cystic epithelia of Cy/+ and Cy/Cy animals. MCP-1 and osteopontin proteins, localized by immunohistochemistry, were weakly detected in +/+ kidneys but were densely expressed in Cy/Cy and in adult Cy/+ kidneys, primarily over cystic epithelium. Increased expression of chemoattractants was associated with the accumulation of ED-1 positive cells (macrophages) in the interstitium of cystic kidneys.
CONCLUSIONS: We suggest that proinflammatory chemoattractants have a role in the development of interstitial inflammation and renal failure in ADPKD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11737583     DOI: 10.1046/j.1523-1755.2001.00065.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  30 in total

1.  Hypertension in Autosomal Dominant Polycystic Kidney Disease: A Clinical and Basic Science Perspective.

Authors:  Shobha Ratnam; Surya M Nauli
Journal:  Int J Nephrol Urol       Date:  2010

Review 2.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

Review 3.  Role of chemokines, innate and adaptive immunity.

Authors:  Kurt A Zimmerman; Katharina Hopp; Michal Mrug
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

Review 4.  Why kidneys fail in autosomal dominant polycystic kidney disease.

Authors:  Jared J Grantham; Sumanth Mulamalla; Katherine I Swenson-Fields
Journal:  Nat Rev Nephrol       Date:  2011-08-23       Impact factor: 28.314

5.  Macrophages promote cyst growth in polycystic kidney disease.

Authors:  Anil Karihaloo; Farrukh Koraishy; Sarah C Huen; Yashang Lee; David Merrick; Michael J Caplan; Stefan Somlo; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2011-09-15       Impact factor: 10.121

6.  Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.

Authors:  Li Chen; Xia Zhou; Lucy X Fan; Ying Yao; Katherine I Swenson-Fields; Mihaela Gadjeva; Darren P Wallace; Dorien J M Peters; Alan Yu; Jared J Grantham; Xiaogang Li
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

Review 7.  Genetic associations in type I interferon related pathways with autoimmunity.

Authors:  Angélica M Delgado-Vega; Marta E Alarcón-Riquelme; Sergey V Kozyrev
Journal:  Arthritis Res Ther       Date:  2010-04-14       Impact factor: 5.156

8.  Constitutive renal Rel/nuclear factor-κB expression in Lewis polycystic kidney disease rats.

Authors:  Michelle H T Ta; Kristina G Schwensen; David Liuwantara; David L Huso; Terry Watnick; Gopala K Rangan
Journal:  World J Nephrol       Date:  2016-07-06

Review 9.  Recent advances in understanding the pathogenesis of polycystic kidney disease: therapeutic implications.

Authors:  Benjamin D Cowley
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Targeting of receptor for advanced glycation end products suppresses cyst growth in polycystic kidney disease.

Authors:  Eun Young Park; Bo Hye Kim; Eun Ji Lee; EunSun Chang; Dae Won Kim; Soo Young Choi; Jong Hoon Park
Journal:  J Biol Chem       Date:  2014-02-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.